Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development
Abnormal activation of SETBP1 through overexpression or missense mutations is highly recurrent in various myeloid malignancies; however, it is unclear whether such activation alone is able to induce leukemia development. Here we show that Setbp1 overexpression in mouse bone marrow progenitors throug...
Main Authors: | Vishwakarma, Bandana A., Nguyen, Nhu, Makishima, Hideki, Hosono, Naoko, Gudmundsson, Kristbjorn O., Negi, Vijay, Oakley, Kevin, Han, Yufen, Przychodzen, Bartlomiej, Maciejewski, Jaroslaw P., Du, Yang |
---|---|
Format: | Online |
Language: | English |
Published: |
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703539/ |
Similar Items
-
Somatic SETBP1 mutations in myeloid malignancies
by: Makishima, Hideki, et al.
Published: (2013) -
SETBP1 Mutations Drive Leukemic Transformation in ASXL1-Mutated MDS
by: Inoue, Daichi, et al.
Published: (2014) -
Resveratrol Mediated Modulation of Sirt-1/Runx2 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells: Potential Role of Runx2 Deacetylation
by: Shakibaei, Mehdi, et al.
Published: (2012) -
MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO
by: Kohrs, Nicole, et al.
Published: (2016) -
CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia
by: Cui, Yajuan, et al.
Published: (2014)